Evaluating risk prediction models for use in lung cancer screening in diverse populations around the world
评估用于世界各地不同人群肺癌筛查的风险预测模型
基本信息
- 批准号:10045047
- 负责人:
- 金额:$ 11.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-08 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AsiaAsiansAustraliaBudgetsCalibrationCancer EtiologyCessation of lifeCountryDataDatabasesDiscriminationEffectivenessEligibility DeterminationEquilibriumEthnic OriginEthnic groupEuropeFundingHispanicsIndividualInternationalKnowledgeLungMalignant neoplasm of lungMinorityMinority GroupsModelingNational Comprehensive Cancer NetworkNot Hispanic or LatinoPerformancePopulationPopulation HeterogeneityProspective cohortRaceResearchResourcesRiskRisk FactorsSmokerSmokingSmoking HistorySmoking and Health ResearchStatistical Data InterpretationTranslatingWorkbasecancer riskcohortcomputed tomography screeningdata harmonizationdata resourcedemographicsevidence baseflexibilityfollow-uplow dose computed tomographylung basal segmentlung cancer screeningmodel developmentmortalitynever smokerportabilitypredictive modelingprogramsrandomized trialrisk prediction modelscreeningscreening guidelinesscreening programtoolvalidation studies
项目摘要
PROJECT SUMMARY
Screening by low-dose computed tomography (CT) can reduce lung cancer mortality among individuals
with a heavy smoking history. Screening is more efficient when eligibility is based on individual risk,
predicted using a model including demographics, smoking, and health information. Individuals whose risk
exceeds a minimum threshold can be offered screening.
Current lung cancer risk models and thresholds were developed and validated in healthy, largely
non-Hispanic white, US populations, and their portability outside that context is unknown. This evidence
gap represents a major and growing concern, because risk-based lung screening efforts are expanding
rapidly worldwide without the needed evidence to support effective implementation.
Therefore, the proposed project will (1) harmonize data across 21 cohorts worldwide to produce a unique
consortium database on lung cancer risk; (2) evaluate the performance of lung cancer risk models across
US races/ethnicities and different countries; (3) build and validate a risk model specifically for Asians; and
(4) calculate the sensitivity of proposed risk thresholds across US and international cohorts.
To achieve these aims, the research team will (1) capitalize on its existing involvement in the Lung Cancer
Cohort Consortium, NCI Cohort Consortium, and Asia Cohort Consortium. Statistical analyses will
(2) quantify calibration (E/O) and discrimination (AUC) of risk models among US whites, blacks, Hispanics,
and Asians, and in countries across Europe, Asia, and Australia; (3) build and validate a flexible parametric
survival model for 5-year lung cancer risk among Asians; and (4) calculate the proportion of ever-smoking
lung cancer cases that would be screening eligible based on proposed risk thresholds.
This work will provide critical data to accelerate implementation of evidence-based, risk-tailored lung cancer
screening programs worldwide, thus maximizing the reductions in lung cancer mortality that can be
achieved through screening with finite resources.
项目摘要
通过低剂量计算机断层扫描(CT)筛查可以降低个体的肺癌死亡率
有大量的吸烟史。当资格基于个人风险时,筛查更有效
使用包括人口统计学,吸烟和健康信息在内的模型进行预测。风险的个人
可以提供超过最小阈值筛选。
当前的肺癌风险模型和阈值是在健康中开发和验证的
非西班牙裔白人,美国人口及其在这种情况以外的便携性是未知的。这个证据
差距代表着一个主要且日益严重的关注,因为基于风险的肺部筛查工作正在扩大
在全球范围内迅速没有必要的证据来支持有效的实施。
因此,拟议的项目将(1)在全球21个同伙之间进行协调,以产生独特的数据
肺癌风险的财团数据库; (2)评估遍布肺癌风险模型的性能
美国种族/种族和不同国家; (3)专门为亚洲人建立和验证风险模型;和
(4)计算我们和国际队列中建议的风险阈值的敏感性。
为了实现这些目标,研究团队将(1)利用其现有参与肺癌的参与
队列联盟,NCI队列联盟和亚洲队列联盟。统计分析将
(2)量化美国白人,黑人,西班牙裔,校准(E/O)和歧视(AUC)(AUC)
亚洲人以及欧洲,亚洲和澳大利亚的国家; (3)构建和验证灵活的参数
亚洲人5年肺癌风险的生存模型; (4)计算不断吸烟的比例
肺癌病例将根据拟议的风险阈值筛查符合条件。
这项工作将提供关键的数据,以加速实施循证,风险标准的肺癌
全球筛查计划,从而最大程度地提高肺癌死亡率的降低
通过使用有限资源进行筛选实现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hilary A. Robbins其他文献
Blood-based DNA methylation markers for lung cancer prediction
用于肺癌预测的血液 DNA 甲基化标记
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
J. Onwuka;Florence Guida;Ryan Langdon;Mikael Johansson;G. Severi;R. Milne;P. Dugué;M. Southey;P. Vineis;T. Sandanger;T. Nøst;M. Chadeau;Caroline Relton;Hilary A. Robbins;Matthew Suderman;Mattias Johansson - 通讯作者:
Mattias Johansson
Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis.
癌症筛查随机临床试验中以死亡率为终点的癌症分期比较:系统评价和荟萃分析。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Xiaoshuang Feng;H. Zahed;Justina Onwuka;Matthew E J Callister;Mattias Johansson;Ruth Etzioni;Hilary A. Robbins - 通讯作者:
Hilary A. Robbins
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment
- DOI:
10.1016/j.arbres.2024.07.007 - 发表时间:
2024-10-01 - 期刊:
- 影响因子:
- 作者:
Daniel Orive;Mirari Echepare;Franco Bernasconi-Bisio;Miguel Fernández Sanmamed;Antonio Pineda-Lucena;Carlos de la Calle-Arroyo;Frank Detterbeck;Rayjean J. Hung;Mattias Johansson;Hilary A. Robbins;Luis M. Seijo;Luis M. Montuenga;Karmele Valencia - 通讯作者:
Karmele Valencia
Hilary A. Robbins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hilary A. Robbins', 18)}}的其他基金
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening
肺早蛋白项目:在肺癌筛查中实施生物标志物的飞跃
- 批准号:
10700985 - 财政年份:2022
- 资助金额:
$ 11.22万 - 项目类别:
Optimizing Screening for HPV-related Cancers among People Living with HIV
优化 HIV 感染者中 HPV 相关癌症的筛查
- 批准号:
9196519 - 财政年份:2016
- 资助金额:
$ 11.22万 - 项目类别:
相似海外基金
Environmental Health in a Changing Climate: the 19th International Conference of the Pacific Basin Consortium for Environment and Health
气候变化中的环境健康:第十九届太平洋盆地环境与健康联盟国际会议
- 批准号:
10307011 - 财政年份:2021
- 资助金额:
$ 11.22万 - 项目类别:
Enhancing Intervention of Attenuated Psychosis Syndrome with M-Health Technology
利用移动健康技术加强对弱化精神病综合征的干预
- 批准号:
9341776 - 财政年份:2017
- 资助金额:
$ 11.22万 - 项目类别:
A Psychobiological Follow-up Study of Transition from Prodrome to Early Psychosis
从前驱症状到早期精神病转变的心理生物学随访研究
- 批准号:
9789368 - 财政年份:2016
- 资助金额:
$ 11.22万 - 项目类别:
A Psychobiological Follow-up Study of Transition from Prodrome to Early Psychosis
从前驱症状到早期精神病转变的心理生物学随访研究
- 批准号:
9202218 - 财政年份:2016
- 资助金额:
$ 11.22万 - 项目类别:
A Psychobiological Follow-up Study of Transition from Prodrome to Early Psychosis
从前驱症状到早期精神病转变的心理生物学随访研究
- 批准号:
10011832 - 财政年份:2016
- 资助金额:
$ 11.22万 - 项目类别: